Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.

Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...

Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.

Michigan hospitals are systematically exploiting a program for low-income patients, according to a new report.

Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York ...

INDIANAPOLIS (Indiana Capital Chronicle) — A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning ...

The American Hospital Association, a Maine hospital group and four nonprofit systems are seeking a temporary restraining order against HHS’ controversial test of a new discount structure in the ...

More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics expand resources and care for underserved communities. By requiring pharmaceutical companies to ...

In politics, there is far too often far too much focus on what’s happening in Washington, D.C. and whatever Beltway politicians and the national media deem to be the “news of the day.” ...

An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...